Summary

A new experimental cancer vaccine is showing promising results in patients diagnosed with melanoma.


Suggested Script

Download full-script: here

Downloadable Content

Download VO: here
Download SOT: here

Expert

Tresa Mcneal, MD, internal medicine at Baylor Scott & White Health

For Interview or More Information

Email Deke.Jones@bswhealth.org

Published on 5/11/23

Script

PROMISING MELANOMA VACCINE
Tresa Mcneal, MD, Internal Medicine, Baylor Scott & White Health


{**ON CAM**}
A NEW EXPERIMENTAL SKIN CANCER VACCINE IS SHOWING PROMISING RESULTS IN PATIENTS WITH A MELANOMA DIAGNOSIS.

{**TAKE VO**}
RESEARCHERS TESTED A NEW M-RNA VACCINE IN PATIENTS ALREADY DIAGNOSED WITH MELANOMA … A FAST-GROWING AND POTENTIALLY FATAL SKIN CANCER.
THE STUDY'S RESULTS SHOWED THAT THE VACCINE TRAINED THE PATIENT'S IMMUNE SYSTEM TO FIGHT MELANOMA CANCER CELLS … CUTTING DOWN THE RATE OF RECURRENCE.
INTERNAL MEDICINE DOCTOR TRESA MCNEAL SAYS THE VACCINE IS STILL IN TRIAL PHASES.

{**TAKE SOT**}
Tresa Mcneal, MD
Internal Medicine
Baylor Scott & White
TRT:15
"We're seeing promising results of it preventing the spread of further melanoma in those patients. This is very exciting news, and it's a great use for seeing an MRNA vaccine that's teaching our body to actually fight cancer cells that could be recurring."

{**ON CAM**}
MCNEAL SAYS ABOUT ONE IN FIVE AMERICANS WILL HAVE SKIN CANCER IN THEIR LIFETIME.
CONCERNED ABOUT YOUR RISK? SHE SAYS THE NUMBER ONE THING YOU CAN DO TO REDUCE IT …. IS TO PROTECT YOUR SKIN FROM SUN EXPOSURE.